Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $700
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $665 to $700.
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $665 to $700.